Correlation Between Nuvalent and Keros Therapeutics
Can any of the company-specific risk be diversified away by investing in both Nuvalent and Keros Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvalent and Keros Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvalent and Keros Therapeutics, you can compare the effects of market volatilities on Nuvalent and Keros Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvalent with a short position of Keros Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvalent and Keros Therapeutics.
Diversification Opportunities for Nuvalent and Keros Therapeutics
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Nuvalent and Keros is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Nuvalent and Keros Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Keros Therapeutics and Nuvalent is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvalent are associated (or correlated) with Keros Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Keros Therapeutics has no effect on the direction of Nuvalent i.e., Nuvalent and Keros Therapeutics go up and down completely randomly.
Pair Corralation between Nuvalent and Keros Therapeutics
Given the investment horizon of 90 days Nuvalent is expected to generate 0.66 times more return on investment than Keros Therapeutics. However, Nuvalent is 1.52 times less risky than Keros Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Keros Therapeutics is currently generating about -0.07 per unit of risk. If you would invest 9,363 in Nuvalent on August 25, 2024 and sell it today you would earn a total of 130.00 from holding Nuvalent or generate 1.39% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Nuvalent vs. Keros Therapeutics
Performance |
| Timeline |
| Nuvalent |
| Keros Therapeutics |
Nuvalent and Keros Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nuvalent and Keros Therapeutics
The main advantage of trading using opposite Nuvalent and Keros Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvalent position performs unexpectedly, Keros Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Keros Therapeutics will offset losses from the drop in Keros Therapeutics' long position.| Nuvalent vs. Eliem Therapeutics | Nuvalent vs. HCW Biologics | Nuvalent vs. RenovoRx | Nuvalent vs. Scpharmaceuticals |
| Keros Therapeutics vs. Ideaya Biosciences | Keros Therapeutics vs. AnaptysBio | Keros Therapeutics vs. MeiraGTx Holdings PLC | Keros Therapeutics vs. Janux Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |